NTRC Therapeutics B.V.

Over NTRC Therapeutics B.V.

NTRC Therapeutics is a precision medicine company that is specialized in discovery and development of innovative kinase inhibitors to treat cancer patients. Using its proprietary EPriL platform NTRC Therapeutics is now developing next-generation kinase inhibitors to treat acquired drug resistance observed in cancer patients treated with first generation inhibitors.

Trefwoorden

• Biotech
• Cell Panel Profiling
• Degraders
• Medicinal Chemistry
• Molecular Pharmacology
• Oncology
• Protein Crystallography
• Target Occupancy
• Target Residence Time Measurements

Adres

• Hoofdkantoor

  Kloosterstraat 95349AB OssNoord-Brabant, Nederland

Team per functiegebied

Gebaseerd op 6 openbare functieprofielen, stand van 3 september 2026.

• Research / R&D5
• Executive / C-Suite1